A5100405778- Health Systems, Economic Evaluations, Quality of Life
- Chronic Disease Management Strategies
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Healthcare Policy and Management
- Diabetes Management and Education
- Diabetes Treatment and Management
- Primary Care and Health Outcomes
- Obesity and Health Practices
- Global Public Health Policies and Epidemiology
- Medication Adherence and Compliance
- Metabolism, Diabetes, and Cancer
- Healthcare cost, quality, practices
- Global Health Care Issues
- Health disparities and outcomes
- Obesity, Physical Activity, Diet
- Diabetes and associated disorders
- Healthcare Systems and Reforms
- Pharmaceutical Practices and Patient Outcomes
- Liver Disease Diagnosis and Treatment
- Pregnancy and preeclampsia studies
- Health Policy Implementation Science
- Pharmaceutical Economics and Policy
- Food Security and Health in Diverse Populations
- Hepatitis B Virus Studies
Centers for Disease Control and Prevention
2015-2024
Fudan University
2024
Ningbo University
2024
Children's Hospital of Chongqing Medical University
2022-2023
Chongqing Medical University
2012-2023
Hubei University of Chinese Medicine
2023
National Center for Chronic Disease Prevention and Health Promotion
2006-2021
People's Hospital of Cangzhou
2021
Nanjing University of Posts and Telecommunications
2021
Jiangsu Cancer Hospital
2021
Background: The Diabetes Prevention Program (DPP) demonstrated that interventions can delay or prevent the development of type 2 diabetes. Objective: To estimate lifetime cost–utility DPP interventions. Design: Markov simulation model to progression disease, costs, and quality life. Data Sources: published reports. Target Population: Members cohort 25 years age older with impaired glucose tolerance. Time Horizon: Lifetime. Perspectives: Health system societal. Interventions: Intensive...
OBJECTIVE The Diabetes Prevention Program (DPP) and its Outcomes Study (DPPOS) demonstrated that either intensive lifestyle intervention or metformin could prevent type 2 diabetes in high-risk adults for at least 10 years after randomization. We report the 10-year within-trial cost-effectiveness of interventions. RESEARCH DESIGN AND METHODS Data on resource utilization, cost, quality life were collected prospectively. Economic analyses performed from health system societal perspectives....
In the United States, diabetes has increased rapidly, exceeding prior predictions. Projections of future burden need to reflect changes in incidence, mortality, and demographics. We applied most recent data available develop an updated projection through 2060. A dynamic Markov model was used project prevalence diagnosed among US adults by age, sex, race (white, black, other). Incidence current were from National Health Interview Survey (NHIS) 1985–2014. Relative mortality NHIS 2000–2011...
To assess the cost implications of diabetes prevention, it is important to know lifetime medical people with relative those without. We derived such estimates using data representative U.S. national population.We aggregated annual expenditures from age diagnosis death determine expenditure. Annual were estimated by sex, at diagnosis, and duration 2006-2009 Medical Expenditure Panel Surveys, which linked 2005-2008 National Health Interview Surveys. combined survival published studies...
OBJECTIVE—To describe the costs of Diabetes Prevention Program (DPP) interventions to prevent or delay type 2 diabetes. RESEARCH DESIGN AND METHODS—We direct medical costs, nonmedical and indirect placebo, metformin, intensive lifestyle over 3-year study period DPP. Resource use cost are summarized from perspective a large health system society. Research excluded. RESULTS—The laboratory tests identify one subject with impaired glucose tolerance (IGT) was $139. Over 3 years, were $79 per...
To assess the relative impact of an intensive lifestyle intervention (ILI) on use and costs health care within Look AHEAD trial.A total 5,121 overweight or obese adults with type 2 diabetes were randomly assigned to ILI that promoted weight loss a comparison condition support education (DSE). Use health-care services recorded across average 10 years.ILI led reductions in annual hospitalizations (11%, P = 0.004), hospital days (15%, 0.01), number medications (6%, < 0.001), resulting cost...
To examine the association of BMI with functional status and self-rated health among US adults how differs by age sex.All analyses are based on National Health Interview Survey (NHIS), 1997-2005, a yearly, representative study household population. We pooled all survey years fitted logistic regression for two sexes three strata (ages 18-44, 45-64, > or =65).Our found that although underweight severe obesity consistently associated increased disability poorer status, overweight moderate show...
To estimate the cost-effectiveness of screening overweight and obese individuals for pre-diabetes then modifying their lifestyle based on Diabetes Prevention Program (DPP).A Markov simulation model was used to disease progression, costs, quality life. Cost-effectiveness evaluated from a health care system perspective. We considered two screening/treatment strategies pre-diabetes. Strategy 1 included subjects giving them intervention in DPP if they were diagnosed with both impaired glucose...
To estimate the health utility scores associated with type 2 diabetes, its treatments, complications, and comorbidities.We analyzed health-related quality-of-life data, collected at baseline during Translating Research Into Action for Diabetes, a multicenter, prospective, observational study of diabetes care in managed care, 7,327 individuals diabetes. We measured using EuroQol (EQ)-5D, standardized instrument which 1.00 indicates perfect health. used multivariable regression to independent...
Background The Diabetes Impact Study followed up a large national population-based screening study to estimate the use of and expenditures for medical care caused by diabetes in China ascertain cost essential basic medicines care. Methods In 2009–10, team interviewed 1482 adults with 1553 glucose tolerance normal range from random samples at 12 sites China. response rate was 67%. Findings After adjusting age, sex, urban/rural location, people received 1.93 times more days inpatient...